Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ria Winkelmann

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Pathologie (Heidelberg, Germany)|November 24, 2025
[Double rarity: the coincidence of two rare salivary gland tumors]Viktoria Haug, Benjamin Ernst, Peter J Wild, et al.
Cancer Treatment Reviews|March 2, 2018
Anal squamous cell carcinoma - State of the art management and future perspectivesDaniel Martin, Panagiotis Balermpas, Ria Winkelmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 13, 2018
Pleomorphic lipomaManuel Jäger, Ria Winkelmann, Kathrin Eichler, et al.
Frontiers in Oncology|December 3, 2019
C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With ChemoradiotherapyDaniel Martin, Franz Rödel, Panagiotis Balermpas, et al.
Frontiers in Immunology|November 1, 2017
Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal CancerDaniel Martin, Franz Rödel, Ria Winkelmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 9, 2018
Pleomorphes LipomManuel Jäger, Ria Winkelmann, Kathrin Eichler, et al.
Oncotarget|March 7, 2022
Sequencing of <i>BRCA1/2</i>-alterations using NGS-based technology: annotation as a challengeSilvana Ebner, Ria Winkelmann, Saskia Martin, et al.
Oncotarget|August 30, 2023
Addendum: Sequencing of <i>BRCA1/2</i>-alterations using NGS-based technology: annotation as a challengeSilvana Ebner, Ria Winkelmann, Saskia Martin, et al.
Oncotarget|November 4, 2021
Comparison of <i>MET</i> gene amplification analysis by next-generation sequencing and fluorescence <i>in situ</i> hybridizationChristina Schmitt, Anna-Alice Schulz, Ria Winkelmann, et al.
Oncology Reports|February 6, 2020
Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapyStefan Vallo, Henner Stege, Maximilian Berg, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Pathologie (Heidelberg, Germany)|November 24, 2025
[Double rarity: the coincidence of two rare salivary gland tumors]Viktoria Haug, Benjamin Ernst, Peter J Wild, et al.
Cancer Treatment Reviews|March 2, 2018
Anal squamous cell carcinoma - State of the art management and future perspectivesDaniel Martin, Panagiotis Balermpas, Ria Winkelmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 13, 2018
Pleomorphic lipomaManuel Jäger, Ria Winkelmann, Kathrin Eichler, et al.
Frontiers in Oncology|December 3, 2019
C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With ChemoradiotherapyDaniel Martin, Franz Rödel, Panagiotis Balermpas, et al.
Frontiers in Immunology|November 1, 2017
Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal CancerDaniel Martin, Franz Rödel, Ria Winkelmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 9, 2018
Pleomorphes LipomManuel Jäger, Ria Winkelmann, Kathrin Eichler, et al.
Oncotarget|March 7, 2022
Sequencing of <i>BRCA1/2</i>-alterations using NGS-based technology: annotation as a challengeSilvana Ebner, Ria Winkelmann, Saskia Martin, et al.
Oncotarget|August 30, 2023
Addendum: Sequencing of <i>BRCA1/2</i>-alterations using NGS-based technology: annotation as a challengeSilvana Ebner, Ria Winkelmann, Saskia Martin, et al.
Oncotarget|November 4, 2021
Comparison of <i>MET</i> gene amplification analysis by next-generation sequencing and fluorescence <i>in situ</i> hybridizationChristina Schmitt, Anna-Alice Schulz, Ria Winkelmann, et al.
Oncology Reports|February 6, 2020
Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapyStefan Vallo, Henner Stege, Maximilian Berg, et al.
Pageof 5